SIRT1 Activation by Small Molecules
暂无分享,去创建一个
David P. Carney | T. Riera | B. Hubbard | R. Stein | R. Perni | G. Vlasuk | April W. Case | B. Szczepankiewicz | Basil P. Hubbard | H. Dai | Thomas Considine | Lauren Kustigian
[1] R. Schnellmann,et al. SRT1720 Induces Mitochondrial Biogenesis and Rescues Mitochondrial Function after Oxidant Injury in Renal Proximal Tubule Cells , 2010, Journal of Pharmacology and Experimental Therapeutics.
[2] A. Railkar,et al. Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675). , 2010, Journal of medicinal chemistry.
[3] J. Baur. Resveratrol, sirtuins, and the promise of a DR mimetic , 2010, Mechanisms of Ageing and Development.
[4] R. Harris,et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. , 2010, The Journal of clinical investigation.
[5] L. Guarente. Sirtuins in aging and disease. , 2007, Cold Spring Harbor symposia on quantitative biology.
[6] J. Olefsky,et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. , 2010, American journal of physiology. Endocrinology and metabolism.
[7] J. Zorn,et al. Turning enzymes ON with small molecules. , 2010, Nature chemical biology.
[8] M. Laakso,et al. SIRT1 mRNA Expression May Be Associated With Energy Expenditure and Insulin Sensitivity , 2010, Diabetes.
[9] D. Sinclair,et al. Mammalian sirtuins: biological insights and disease relevance. , 2010, Annual review of pathology.
[10] Venkataraman Thanabal,et al. SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.
[11] Shu-Chen Lu,et al. Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity , 2009, Chemical biology & drug design.
[12] Brian C. Smith,et al. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. , 2009, Analytical biochemistry.
[13] K. Tsuneyama,et al. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[14] M. McBurney,et al. SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol , 2009, Oncogene.
[15] D. Selkoe,et al. Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening , 2009, PloS one.
[16] Amy V. Lynch,et al. Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators. , 2009, Bioorganic & medicinal chemistry letters.
[17] David J. Gagne,et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo , 2009, BMC Syst. Biol..
[18] David P. Carney,et al. Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3 , 2009, Protein science : a publication of the Protein Society.
[19] Amy V. Lynch,et al. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. , 2009, Journal of medicinal chemistry.
[20] J. Olefsky,et al. SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes , 2008, Molecular and Cellular Biology.
[21] J. Auwerx,et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.
[22] J. Yates,et al. A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.
[23] Amy V. Lynch,et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.
[24] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[25] J. Boeke,et al. The biochemistry of sirtuins. , 2006, Annual review of biochemistry.
[26] S. Fields,et al. Substrate-specific Activation of Sirtuins by Resveratrol* , 2005, Journal of Biological Chemistry.
[27] Brian C. Smith,et al. Mechanism of Human SIRT1 Activation by Resveratrol* , 2005, Journal of Biological Chemistry.
[28] L. Hersh,et al. ATP Effects on Insulin-degrading Enzyme Are Mediated Primarily through Its Triphosphate Moiety* , 2004, Journal of Biological Chemistry.
[29] K. Glaser,et al. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction. , 2004, Analytical biochemistry.
[30] J. Denu,et al. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. , 2004, Biochemistry.
[31] Namjin Chung,et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ , 2004, Nature.
[32] Phuong Chung,et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.
[33] V. Schramm,et al. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. , 2003, Biochemistry.
[34] J. Boeke,et al. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. , 2001, Biochemistry.
[35] P. Reichard,et al. Allosteric control of the substrate specificity of the anaerobic ribonucleotide reductase from Escherichia coli. , 1994, The Journal of biological chemistry.
[36] R. Stein,et al. Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase. , 1986, The Journal of biological chemistry.
[37] J. Changeux,et al. Allosteric proteins and cellular control systems. , 1963, Journal of molecular biology.
[38] A. G. Cooper,et al. Allosteric activation of the hydrolysis of specific substrates by chymotrypsin. , 1976, European journal of biochemistry.
[39] F. Wedler. Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady‐state enzyme systems. Author: Irwin H. Segal (University of California, Davis). Published by Wiley‐Interscience, New York, 1975. Price: $24.50. No. of pages: 957 , 1976 .